Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
NCT ID:
NCT05227703
Pre Assignment Details:
The ITT population included all randomized participants and was used for the Demographic and Baseline Characteristics. The modified ITT (mITT) population included all randomized participants who received at least one dose of study drug, had a baseline assessment, and had at least 1 postbaseline PANSS assessment. The mITT population was used for the efficacy evaluations. The FAS included all randomized participants who receive at least one dose of study drug and was used for the safety analysis.
Recruitment Details:
Participants were randomly assigned at a ratio of 1:1:1 to one of three treatment groups (Emraclidine 15 mg QD, Emraclidine 30 mg QD, or Placebo). Randomization was stratified by geographic region (United States or all other countries).
Study:
NCT05227703
Study Brief:
Results Section:
NCT05227703